General Interest | Page 68 of 169 | Links Medicus Content Curation & Alerts in Medicine

Review: The duration of infectiousness of individuals infected with SARS-CoV-2

15 Oct, 2020 | 09:26h | UTC

The duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection

Commentary on Twitter

🔥NEW Review🔥#COVID19 pts with mild-to-moderate illness are highly unlikely to be infectious beyond 10 ds from symptom onset , However, limited studies found that Immunocompromised and severe-to-critical patients may be infectious for >10 days https://t.co/hogXvFpPEb pic.twitter.com/fBm5Se4RBf

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 13, 2020

Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts

15 Oct, 2020 | 09:17h | UTC

Coronavirus vaccine: what we know so far – a comprehensive guide by academic experts – The Conversation

The 4 simple reasons Germany is managing Covid-19 better than its neighbors

15 Oct, 2020 | 09:19h | UTC

The 4 simple reasons Germany is managing Covid-19 better than its neighbors – Vox

WHO Global tuberculosis report 2020

15 Oct, 2020 | 09:35h | UTC

Global tuberculosis report 2020 – World Health Organization

News release: WHO: Global TB progress at risk – World Health Organization

Executive summary: Global tuberculosis report 2020

Commentary: WHO warns of COVID impact on TB services – CIDRAP

Commentary on Twitter

The 🌏🌍🌏 has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop in deaths between 2015 and 2019.

🚨 #COVID19 will lead to setbacks if no action is taken urgently, according to 🆕 WHO report 👉https://t.co/5BvbGjaudU pic.twitter.com/A4edYfyOBH

— World Health Organization (WHO) (@WHO) October 14, 2020

Richard Smith: Are all lives and deaths equal?

15 Oct, 2020 | 08:58h | UTC

Richard Smith: Are all lives and deaths equal? – The BMJ Opinion

Genomic evidence for reinfection with SARS-CoV-2: A case study

14 Oct, 2020 | 09:39h | UTC

Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases

Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME

Perspective: Why does a high-impact publication matter so much for a career in research?

15 Oct, 2020 | 08:56h | UTC

Why does a high-impact publication matter so much for a career in research? – Nature

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

14 Oct, 2020 | 09:31h | UTC

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT

News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials

Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – Health Policy Watch AND Johnson & Johnson pauses Covid-19 vaccine trial after ‘unexplained illness’ – CNN

Monoclonal antibody trial halted for safety concern

14 Oct, 2020 | 09:30h | UTC

Monoclonal Antibody Trial Halted for Safety Concern – Brief19

COVID-19 will probably become endemic – here’s what that means

14 Oct, 2020 | 09:27h | UTC

COVID-19 will probably become endemic – here’s what that means – The Conversation

[Abstract Only] Randomized trials: Efficacy and safety of a plant-derived influenza vaccine in adults

14 Oct, 2020 | 09:23h | UTC

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials – The Lancet (link to abstract – $ for full-text)

Commentary on Twitter

NEW—First large-scale studies of plant-derived, quadrivalent, virus-like particle influenza vaccine show substantial protection against respiratory illness & influenza-like illness caused by influenza viruses in adults: two randomised phase 3 trials https://t.co/oQbs2uJTXY pic.twitter.com/C6b6Qi6qZ7

— The Lancet (@TheLancet) October 13, 2020

Case report: Sudden irreversible hearing loss post COVID-19

14 Oct, 2020 | 09:24h | UTC

Sudden irreversible hearing loss post COVID-19 – BMJ Case Reports

Commentaries: Coronavirus: Patient has sudden permanent hearing loss – BBC AND First reported UK case of sudden permanent hearing loss linked to COVID-19 – BMJ

Commentary on Twitter

Sudden hearing loss after #COVID19.
Report of 1st UK case and review of the other 4 published reports (must be *extremely rare*)https://t.co/wCkrgHcwKH pic.twitter.com/onQxxYiImb

— Eric Topol (@EricTopol) October 13, 2020

Opinion piece by Dr. John P.A. Ioannidis: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic

13 Oct, 2020 | 01:15h | UTC

Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic – European Journal of Clinical Investigation

Pursuing COVID ‘herd immunity’ without a vaccine could be dangerous & unethical, WHO warns

13 Oct, 2020 | 01:16h | UTC

Pursuing COVID ‘Herd Immunity’ Without A Vaccine Could Be Dangerous & Unethical, WHO Warns – As World Reaches Record Peaks For New Infections – Health Policy Watch

‘Long Covid’: Why are some people not recovering?

13 Oct, 2020 | 01:03h | UTC

‘Long Covid’: Why are some people not recovering? – BBC

Infecting volunteers with coronavirus may be one way to test potential vaccines. But there are risks.

13 Oct, 2020 | 01:02h | UTC

Infecting volunteers with coronavirus may be one way to test potential vaccines. But there are risks – The Conversation

Research integrity: Nine ways to move from talk to walk

13 Oct, 2020 | 01:01h | UTC

Research integrity: nine ways to move from talk to walk – Nature

The end of dengue fever? Mosquito experiment in Indonesia sees huge reduction in cases

13 Oct, 2020 | 00:59h | UTC

The end of dengue fever? Mosquito experiment in Indonesia sees huge reduction in cases – South China Morning Post

Study: Three quarters of people with SARS-CoV-2 infection were asymptomatic the day they took the test

12 Oct, 2020 | 00:46h | UTC

Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data – Clinical Epidemiology

Commentaries: Covid: more than 80% of positive UK cases in study had no core symptoms – The Guardian AND Symptoms of COVID-19 are a poor marker of infection, new UK population study shows – Taylor & Francis Group AND Expert reaction to analysis of asymptomatic SARS-CoV-2 infection from English Household Survey data – Science Media Centre

Opinion: Continual lockdowns are not the answer to bringing Covid under control

12 Oct, 2020 | 00:42h | UTC

Continual lockdowns are not the answer to bringing Covid under control – The Guardian

Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset

12 Oct, 2020 | 00:44h | UTC

Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset – Clinical Microbiology and Infection

Commentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg

Commentary on Twitter

Follow-up of adults with non-critical COVID-19 two months after symptoms' onset – Clinical Microbiology and Infection Two thirds of adults with non-critical COVID-19 had persistent symptoms up to 2 months after symptom onset. https://t.co/xZk2DURyTG

— Carlos del Rio (@CarlosdelRio7) October 10, 2020